Skip to main content

Advertisement

Log in

Prophylactic dexamethasone effectively reduces the incidence of pain flare following spine stereotactic body radiotherapy (SBRT): a prospective observational study

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this study was to determine the incidence of pain flare (PF) in patients receiving spine stereotactic body radiotherapy (SBRT) treated with prophylactic oral dexamethasone (DEX) 1 h before and for 4 days following SBRT.

Methods

Forty-seven patients were accrued on this prospective observational study. The first cohort of 24 patients was treated with 4 mg, while a second cohort of 23 patients treated with 8 mg of DEX. The Brief Pain Inventory (BPI) was used to score pain and functional interference each day during SBRT and for 10 days following. Comparisons between the 4 and 8 mg cohorts, in addition to our previously reported steroid naïve patients post SBRT (n = 41), were also performed.

Results

The total incidence of PF was 19 % (9/47). The incidence in the 4 and 8 mg cohorts was 25 % (6/24) and 13 % (3/23), respectively, and the difference was not statistically significant (p = 0.46). Comparing functional interference, the 4 mg cohort had better profile in walking ability (p < 0.005) and relationships with others (p < 0.035) compared to the 8 mg cohort. Compared to our previously reported steroid naïve cohort, prophylactic DEX significantly reduced the incidence of PF (68 vs. 19 %, p < 0.0001, respectively), patients had lower worst pain scores, and improved general activity interference outcome.

Conclusion

We recommend prophylactic DEX for patients treated with spine SBRT. Our current practice is based on the 4 mg protocol primarily due to the improved functional interference outcomes. A randomized trial is required to finalize the optimal regimen and schedule.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Sahgal A, Bilsky M, Chang EL et al (2011) Stereotactic body radiotherapy for spinal metastases: Current status, with a focus on its application in the postoperative patient. J Neurosurg Spine 14(2):151–66. doi:10.3171/2010.9.SPINE091005

    Article  PubMed  Google Scholar 

  2. Sahgal A, Chou D, Ames C et al (2007) Image-guided robotic stereotactic body radiotherapy for benign spinal tumors: the university of california san francisco preliminary experience. Technol Cancer Res Treat 6(6):595–604

    Article  CAS  PubMed  Google Scholar 

  3. Sahgal A, Larson DA, Chang EL (2008) Stereotactic body radiosurgery for spinal metastases: a critical review. Int J Radiat Oncol Biol Phys 71(3):652–65. doi:10.1016/j.ijrobp.2008.02.060

    Article  PubMed  Google Scholar 

  4. Sahgal A, Roberge D, Schellenberg D et al (2012) The Canadian association of radiation oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy. Clin Oncol (R Coll Radiol) 24(9):629–39. doi:10.1016/j.clon.2012.04.006

    Article  CAS  Google Scholar 

  5. Lo SS, Sahgal A, Chang EL et al (2013) Serious complications associated with stereotactic ablative radiotherapy and strategies to mitigate the risk. Clin Oncol (R Coll Radiol) 25(6):378–87. doi:10.1016/j.clon.2013.01.003

    Article  CAS  Google Scholar 

  6. Sahgal A, Weinberg V, Ma L et al (2013) Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practice. Int J Radiat Oncol Biol Phys 85(2):341–7. doi:10.1016/j.ijrobp.2012.05.007

    Article  PubMed  Google Scholar 

  7. Sahgal A, Ma L, Weinberg V et al (2012) Reirradiation human spinal cord tolerance for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 82(1):107–16. doi:10.1016/j.ijrobp.2010.08.021

    Article  PubMed  Google Scholar 

  8. Sahgal A, Ma L, Gibbs I et al (2010) Spinal cord tolerance for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 77(2):548–53. doi:10.1016/j.ijrobp.2009.05.023

    Article  PubMed  Google Scholar 

  9. Sahgal A, Atenafu EG, Chao S et al (2013) Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score. J Clin Oncol 31(27):3426–31. doi:10.1200/JCO.2013.50.1411

    Article  PubMed  Google Scholar 

  10. Cunha MV, Al-Omair A, Atenafu EG et al (2012) Vertebral compression fracture (VCF) after spine stereotactic body radiation therapy (SBRT): Analysis of predictive factors. Int J Radiat Oncol Biol Phys 84(3):e343–9. doi:10.1016/j.ijrobp.2012.04.034

    Article  PubMed  Google Scholar 

  11. Chiang A, Zeng L, Zhang L et al (2013) Pain flare is a common adverse event in steroid-naive patients after spine stereotactic body radiation therapy: a prospective clinical trial. Int J Radiat Oncol Biol Phys 86(4):638–42

    Article  PubMed  Google Scholar 

  12. Cleeland CS, Ryan KM (1994) Pain assessment: Global use of the brief pain inventory. Ann Acad Med Singap 23(2):129–38

    CAS  PubMed  Google Scholar 

  13. Hird A, Wong R, Flynn C et al (2009) Impact of pain flare on patients treated with palliative radiotherapy for symptomatic bone metastases. J Pain Manag 4(2):401–6

    Google Scholar 

  14. Chow E, Loblaw A, Harris K (2007) Dexamethasone for the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a pilot study. Support Care Cancer 15(6):643–7

    Article  PubMed  Google Scholar 

  15. Wang XS, Rhines LD, Shiu AS et al (2012) Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1–2 trial. Lancet Oncol 13(4):395–402. doi:10.1016/S1470-2045(11)70384-9

    Article  PubMed Central  PubMed  Google Scholar 

  16. Walker PW, Palla S, Pei BL et al (2008) Switching from methadone to a different opioid: what is the equianalgesic dose ratio? J Palliat Med 11(8):1103–8. doi:10.1089/jpm.2007.0285

    Article  PubMed Central  PubMed  Google Scholar 

  17. Hird A, Zhang L, Holt T et al (2009) Dexamethasone for the prophylaxis of radiation-induced pain flare after palliative radiotherapy for symptomatic bone metastases: a phase II study. Clin Oncol (R Coll Radiol) 21(4):329–35. doi:10.1016/j.clon.2008.12.010

    Article  CAS  Google Scholar 

  18. Pan HY, Allen PK, Wang XS et al (2014) Incidence and predictive factors of pain flare after spine stereotactic body radiation therapy: Secondary analysis of phase 1/2 trials. Int J Radiat Oncol Biol Phys. doi:10.1016/j.ijrobp.2014.07.037

    Google Scholar 

Download references

Acknowledgments

None

Conflict of interests

Dr. Arjun Sahgal has received honorarium for previous educational seminars for Medtronic Kyphoplasty division and for Elekta AB and has research grants from Elekta AB, otherwise, there are no conflicts of interest to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Arjun Sahgal.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khan, L., Chiang, A., Zhang, L. et al. Prophylactic dexamethasone effectively reduces the incidence of pain flare following spine stereotactic body radiotherapy (SBRT): a prospective observational study. Support Care Cancer 23, 2937–2943 (2015). https://doi.org/10.1007/s00520-015-2659-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-015-2659-z

Keywords

Navigation